Our Specialists

George Marcoullis, M.D., Ph.D

George Marcoullis, M.D., Ph.D

Oncology / Hematology

Amer. Brd. (Inter. Med.)
Amer. Brd. (Med. Oncol.)
Eur. Soc. (Med. Oncol)
Cyp. Coun. (Hemat.& Oncol.)

Mail Address: 12 Kasos Street, Apt 121, Building THETA 1086 Ayioi Omoloyites, Nicosia Cyprus
Telephone: +357 22502285, +357 22519342, +357 99097427
Fax: +357 22351938
Email: g.marcoullis@hippocrateon.com

GEORGE MARCOULLIS, M.D., Ph.D
(Abbreviated CV 27.05.2013)

Dr Marcoullis, is currently Professor of Medicine, Chairman of the Preparatory Committee for the Organization of the Medical School at the European University Cyprus and Director of Oncology/Hematology at the Hippocrateon Hospital, Cyprus. He was, previously, the Dean of School of Health Sciences, Frederick University Cyprus, Associate Professor of Medicine at the New York Medical College (NYMC) and Chief of the Blood and Marrow Stem Cell Transplant Unit at Our Lady of Mercy Medical Center (OLM)

Dr Marcoullis completed his training in Medicine, Oncology, Hematology and stem cell transplantation at the New York Medical College, Albert Einstein College of Medicine and Montefiore Medical Center in New York by 1986; he has had specialized training/attachments at John Hopkins, National Institutes of Health, Finland and France.. He is certified in medical Oncology, Hematology, and Internal Medicine by/or the American Board of Internal Medicine, European Society of Clinical Oncology and the Cyprus Medical Council; he became member of the American Societies of Clinical Oncology, Hematology and Blood and Marrow Transplantation and the European Society of Medical Oncology.

Dr Marcoullis served as Chief of Hematology/Oncology in Medical Centers in the USA and Europe; he published more than 50 original papers and book chapters and hundreds of articles; he received funding and Awards from: NIH, INSERM (France), Veterans Administration (USA), WHO, Universities of Nancy; Athens and Helsinki.

He served as: Vice President of the “Committee for Solidarity with the AIDS Patients and Families”, Founding member of the “Movement for the Patient Rights”, member of the Board of Directors of the Cyprus Anti-Cancer Society where he co-organized the first “Day Center for Cancer Patients” in Cyprus; he co-directed several Public Awareness campaigns against cancer; he was elected twice to the Board of National Representatives of ESMO and Vice President of the Cyprus Oncological Society.

 

The Medical Oncology, Hematology and Chemotherapy Sections at the Hippocrateon Private Hospital are fully equipped  units constantly supported by a wide spectrum of all medical and surgical subspecialties and ancillary services needed for the safe and state of the art treatments/procedures required in the management of oncological and blood diseases collectively. Special Clinics, like “Breast Clinic” offer a team full-range approach in the management of complicated or contravential cases.

The Center is ideal for individuals seeking most effective modern up-to-date answers to difficult or otherwise catastrophic diseases like cancer, leukemia, bleeding/thomboembolic disorders, anemias, immunodeficiency states, cytopenias e.t.c., and early diagnosis/prevention/prophylaxis and prolypsis against acquired and genetic diseases like cancer.

Board certified attending physicians and registered nurses and all other health professionals integral to the efficient routine and specialized management are available on the premises for patients needing: Chemotherapy, Transfusions, Venesections, Recuperation from oncological surgery or Radiotherapy or Transplantation while stationed or working or vacationing in Cyprus.

The Center is affiliated with other pertinent Centers of Excellence in the USA, Great Britain, Israel, Greece and elsewhere offering unique opportunities for most productive and effective collaboration with specialized teams all over the World. More than that the Center encompasses services for the diagnosis, Prevention, Screening, Palliation, Supportive care and Treatment of Cancer, Leukemias, Lymphomas, Anemias, Leukopenias, Thrombocytopenias and other Blood Cell Diseases, Bleeding Disorders, Thomboembolic complications, Transplantations, Aplastic Anemias and Immunologic Disorders.

ORIGINAL PAPERS:

Marcoullis, G. and Grasbeck, R.: Vitamin B12-binding proteins in human gastric mucosa.  General pattern and demonstration of intrinsic factor isoproteins typical of mucosa. Scand. J. Clin.  Lab.  Invest. 35: 5-11, 1975

Grasbeck, R. and Marcoullis, G.: Studies on a fraction of human gastric mucosa containing intrinsic factor isoproteins typical of mucosa.  Scand.  J. Clin.  Lab.  Invest. 35: 13-18, 1975.

Marcoullis, G. and Grasbeck, R.: Preliminary identification and characterization of antigen extracts from Onchocerca volvulus.  Trop.  Parasit. 27: 314-322, 1975.

Marcoullis, G. and Grasbeck, R.: Solubilized intrinsic factor receptor from pig ileum and its characteristics. Biochim. Biophys. Acta 496: 36-51, 1977.

Marcoullis, G, Grasbeck, R. and Salonen, E.-M.: Identification and characterization of intrinsic factor and cobalophilin from pig ileal and pyloric mucosa. Biochim Biophys. Acta 497: 663-672, 1977.

Marcoullis, G.: Studies on the solubilized porcine ileal intrinsic factor receptor and on a 340, 000 dalton component binding vitamin B12.  Biochim.  Biophys.  Acta 499, 373-381, 1977.

Marcoullis, G. and Grasbeck, R.: Isolation of the ileal intrinsic factor receptor of the pig.  Scand.  J. Clin.  Lab. Invest, 174 (Suppl.): 95, 1977.

Marcouliis, G. et al: Parasite antigens. (Review) Bull. World Health Organiz. 52: 237-249, 1975.

Marcoullis, G. and Grasbeck, R.: Isolation of the porcine ileal intrinsic factor receptor by sequential affinity chromatography. Biochim.  Biophys.  Acta. 499: 309-314, 1977.

Marcoullis," G.: Le facteur intrinseque et ses anticorps.  In: Cours d’ immunohematologie et d' immunopathologie Medicales Institut Pasteur, 47: 361-394, 1977.

Marcoullis, G., Salonen, R.-M. and Grasbeck, R.: Isolation of vitamin B12-binding proteins by combined immuno and affinity chromatography.  Comparative studies on the isolated and unisolated proteins.  Biochim.  Biophys.  Acta. 495: 336-348, 1978.

Marcoullis G., Salonen, E. -M and Grasbeck, R.: Sequential affinity chromatography for the purification of antigens from Onchocerca volvulus adult worms. Trop.  Parasit. 29: 3948, 1978.

Marcoullis, G., Salonen, E.-M. and Grasbeck, R: Porcine serum cobalophilin and transcobalamin. Identification isolation and properties including electro focusing patterns. Biochim.  Biophys.  Acta. 534: 48-57, 1978.

Marcoullis, G., Merivuori, H. and Grasbeck, R.: Comparative studies on intrinsic factor and cobalophilin in different parts of the gastrointestinal tract of the pig.  Biochim.  J. 173: 705-712. 1978.

Marcoullis, G.: Soluble and membrane-bound proteins involved in vitamin B12 transport.  Helsinki University, Finland, Academic Dissertation, 1978.

Marcoullis, G., Parmentier, Y. and Nicolas, J. -P.: Blocking and binding type antibodies against all major vitamin B12 binders in a pernicious anaemia serum.  Brit.  J. Haem 43: 15 -26, 1979.

Parmentier, Y., Marcoullis, G. and Nicolas, J. -P.: The intraluminal transport of vitamin B12 and the exocrine pancreatic insufficiency.  Proc.  Soc.  Exp.  Biol.  Med. 160: 396-400, 1979.

Parmentier, Y., Marcoullis, G., Nicolas, J.-P. and Perrin, M-0. : The intraluminal phase of vitamin B12 transport in the human. In: Vitamin B12 (Zagalak, B and Friedrich, G., Editors) Walter de Gruyter.  Berlin, New York 6: 803-807, 1979.

Marcoullis, G., Rothenberg, S.P. and Labombardi, V.: Preparation and characterization of proteins in the alimentary tract of the dog which bind cobalamin and intrinsic factor.  J. Biol.  Chem. 255 (5): 1824-1829, 1979.

Marcoullis, G., Parmentier, Y., Nicolas, J.P., Jimenez, M. and Gerald, P.: Cobalamin malabsorption due to non degradation of R proteins in the human intestine.  J. Clin. Invest. 66: 430-440;1980.

Marcoullis, G., Nicolas, J.-P, Parmentier, Y., Jimenez M. and Gerard, P.: A derivative of R type cyanocobalamin binding proteins in the human intestine: A candidate antibacterial molecule. Biochim. Biophys. Acta. 633: 289-294, 1980.

Nicolas, J.-P., Marcoullis.  G.: Role des enzymes pancreatiques dans le transport intraliminal et l’absorption in leale de la vitamin B12.  C.R. Soc. Biol. 174: 548-563, 1980.

Nicolas, J.-P., Marcoullis.  G., Parmentier, Y., Bigard, J.A., Gaucher, P., Jimenez, M. and Gerard, P.I The role of pancreatic enzymes in the intraluminal transport and ileal absorption of vitamin B12.  Ann. Nutr.  Al. 34 (3): 504-505, 1980.

Nicolas, J.-P., Jimenez, M., Marcoullis, G and Parmentier,Y.: In vivo evidence that intrinsic factor cobalamin complex traverses the human intestine intact.  Biochim.  Biophys.  Acta 675: 328-333, 1981.

Marcoullis, G. and Rothenberg, S.P.: Intrinsic factor-mediated vitamin B12 absorption in the dog.  Am. J. Physiol. 241: G294-G299, 1981.

Marcoullis, G. Gueant, J. L. and Nicolas J.-P: Development of a radioimmunoassay specific for exocrine pancreatic insufficiency.  Institute National Industriel, France, Patent No. 8120345, 1981.

Marcoullis, G. and Rothenberg, S.P.: The functional activity of intrinsic factor measured using solubilized receptor protein.  Clin. Chem. 28(8): 1794-1796, 1982.

Rothenberg, S.P. and Marcoullis, G.: Measurement of cobalamin analogues in biological material by current techniques is erroneous, Clin. Chem.29 (8): 1557 –1576, 1983.

Marcoullis, G. and Rothenberg, S.P.: Macromolecules in the assimilation and transport of cobalamin.  In: Nutrition in Haematology. Contemporary Issues in Clinical Nutrition.  Lidenbaum, editor, Churchill Livingstone Inc.  New York. 5: 59-119, 1983.

Marcoullis, G. and Nicolas, J.-P.: The interactions of cobalamin in the gastrointestinal tract.  In: Progr. Gastroent.  Glass, G.B.J., Sherlock, P. eds.  Grune & Stratton, New York, Volume IV: 133-172, 1983.

Rothenberg, S.P. and Marcoullis, G.: Development of a radioimmunoassay which distinguishes between cyanocobalamin and analogues.  J. Lab. Clin.  Invest. 103 (6): 959-972, 1984.

Marcoullis, G. and Rothenberg, S.P.: Isolation and characterization of two species of receptor which bind intrinsic factor.  Archives Biochem.  Biophys. 235(2): 482 -492, 1984.

Marcoullis, G., Gueant, J.L. and Nicolas, J.-P.: Radioimmunoassay assessing for exocrine pancreatic insufficiency, based on the differential enzymatic degradation of cobalamin-binding proteins.  Clin. Chem. 32: 453-460, 1986.

Marcoullis, G.: Medical Oncology in Cyprus; A Success story and triumph for cancer patients.  Europ. Soc. Med. Oncol. Newsletter. 2: 6-8, 1995.

Marcoullis, G., Treleaven, J. and Mehta.  J.: Autologous Bone Marrow and Peripheral blood stem cell Transplantation in Hematological Malignancies: Current status. Med. Oncol. 1996, 12: 209-218.

Dutcher JP, Novik Y, O’Boyle K, Marcoullis G, Secco C. and  Wiernik PH:  Twentieth century 
advances in drug therapy in oncology. Part I. J Clin Pharmacol 40:1007-1024,2000.

Dutcher JP, Novik Y, O’Boyle K, Marcoullis G. Secco C. and Wiernik PH: Twentieth century
Advances in drug therapy in oncology. Part II. J Clin Pharmacol 40:1079-1092, 2000

Marcoullis G., Abebe L. Jain D., Talusan R., Bhagwati N., and Wiernik P. H. :Microangiopathic hemolysis refractory to plasmapheresis responding to docetaxel and cisplatin  Medical Oncology 19:189-192, 2002

ABSTRACTS:

Grasbeck, R. and Marcoullis, G.: Specific intrinsic factor isoproteins in human gastric mucosa.  Abstracts of the European Society for Clinical Investigation. Rotterdam, April 25-27, 1974, p.116.

Marcoullis, G. and Grasbeck, R.: Intrinsic factor receptor and vitamin B12-binding proteins in pig ileum. Abstracts of International Congress of Biochemistry. Hamburg, July 25-31, 1976, Abs No. 05-4-273.

Nicolas, J.P., Parmentier, Y. and Marcoullis, G.: Free and biologically active intrinsic factor in the human intestinal juice. Abstracts of the X International Congress of Clinical Chemistry.  P.71-Mexico, February 26-March 3, 1978.

Marcoullis, G., Nicolas, J.P., Parmentier, Y. and Perrin, M.O.: Two antibody types against all vitamin B12-binders in a pernicious anaemia serum. Abstracts of XVII International Congress of Haematology. P. 750, Paris, July, 1978, Paris, Abs No 59/1181-41.

Marcoullis, G. and Grasbeck, R.: Isolation of the intrinsic factor receptor of the pig.  Abstracts of XVI Nordiska Kongressen for Klinisk Fysiologi. Oulu, Finland, June 28-30, 1977, Abs No. 119.

Parmentier, Y., Nicolas, J.P. and Marcoullis.  G.: Le transit intestinal de la vitamin B12 chez I’homme. Gastroent. Clin, Biol. 3, 79, 1979.

Pamentier, Y., Marcoullis, G. and Nicolas, J.P.: Free intrinsic factor in the human intestinal juice.  Ann. Nutr. Aliment 33: 287-288, 1979.

Parmentier, Y., Marcoullis, G. and Nicolas, J.P.: Premiere mise en evidence et caracterisation d'anticorps diriges contre les transporteurs de vitamin B12 chez I’homme.  Ann. Nutr. Aliment, 33: 531-532, 1979.

Parmentier, Y., Marcoullis, G. and Nicolas, J.P.: Miss en 'evidence d'anticorps des deux types diriges contre I'ensemble des transporteurs de vitamin B12 chez un sujet porteur d'anemie de Biermer.  In the Abstracts of the Reunion Francophons sur le theme "Les Immunoglobulines".  Bandol, France, August 1979.

Nicolas, J.P., Marcoullis, G. Parmentier, Y., Bigard, M.A., Gaucher, P., Jimenez, M. and Gerard, P.: Le role des enzymes pancreatiques dans le transport intraluminal et le absorption ileale de la vitamin B12 (Cbl) . Societe Francaise de Nutrition-Lyon-janvier, 1980.

Marcoullis, G., Rothenberg, S.P. and Jimenez, M.: Conformational changes of the receptor molecule in its interaction with intrinsic factor. 65th Annual Meeting FASEB.  Georgia, April 12-17, 1981.

Rothenberg, S.P, Marcoullis, G. and Lader, E. : Antiserum to cyanocobalamin distinguishes physiologic cobalamins from cobinamide analog.  Clin. Res. 30: A560, 1982.

Marcoullis, G. and Rothenberg, S.P.: Isolation and characterization of two receptor species for intrinsic factor.  Fed. Proc. 41: 1683, 1982.

Rothenberg, S.P., Marcoullis, G. and Schwarz, S.: Human serum contains cobinamide which falsely elevates the cobalamin by R-protein radioassay.  Annual Meeting of the American Society of Haematology, San Francisco, December 1983.

Ciobanu, N., Sparano, JA., Gucalp, R., Dutcher, J., Walewski, J., Marcoullis, G. and Wiernik, PH.: High dose Cisplatin (P), Carmustine (C) and Thiotepa (T) plus autologous bone marrow transplantation (ABMT) in advanced cancer.  Proc. Am.  Soc. Clin. Oncol. 12: 463, 1993

  • Amer. Brd. (Inter. Med.)
  • Amer. Brd. (Med. Oncol.)
  • Eur. Soc. (Med. Oncol)
  • Cyp. Coun. (Hemat.& Oncol.)

EDUCATIONAL ACTIVITIES:

AWARDS:

European School of Oncology; “For contribution in the scientific development of the School”; 1997

CURRICULA & SEMINARS:

Chairperson: In  “Multiple Myeloma and Paraproteinemias”; Departments of “Renal Diseases” and “Haematology”, Nicosia General Hospital, Cyprus; February 23, 2006

Chairperson: In the “Lymphoma Sessions”, European Society of Medical Oncology, 23rd Congress, November 6 -10, 1998

Chairperson: in the “Leukemias and Myeloma Sessions”, European Society of Medical     Oncology, 21st Congress, November 1- 5, 1996

Organizing Committee- Member: 1996- European Group for Breast Cancer  Screening, September 27 - 28, 1996

Organizing Committee - Member: Planning and Development of “The Tumor Registry of Cyprus”, 1991-1998

SERVICE:

Board Member: European Society of Medical Oncology, National Representatives Committee, 1992 -1999; Re-elected: January, 2006 

Project Director: Planning, Fund Raising and Development of a “Day Center for Cancer patients” in Cyprus, 1996 – 1998

Board of Directors- Member: Cancer Society of Cyprus, 1991 – 1998

LECTURES:

Testicular Tumors; 1998 – Word Hellenic Biomedical Conference, New York, December 5-6, 1998

Management of Advanced Non-seminomatous Germ Cell Cancer: European School of Oncology Seminar, Cyprus, 1998

Cancer Prevention; Nicosia Medical Association Conference, Cyprus, April 24 – 25, 1999

Reducing your Cancer Risk; Women’s Health & Wellness Conference: Hellenic American Women’s Council, Washington D.C., May 10, 2003

Meet the Doctor: Latest Treatments in Blood Cancers: The Leukemia & Lymphoma Society, Erie PA, April 27, 2005

Current Management of Haematological Malignancies: 8th Marianna Lordos Seminar; Nicosia, Cyprus; February 10-12, 2006

Advances/Developments in Current Treatment of Cancer: Cyprus Free University; Nicosia, Cyprus; January 11, 2006

Advances/Developments in Current Treatment of Cancer: Limassol Free University; Evagoras Lanitis Cultural Center, Limassol, Cyprus; January 30, 2006

Myoskeletal Manifestations in Malignant Diseases; 6th Annual Meeting of the Cyprus Orthopedics and Trauma Surgical Society, Nicosia, Cyprus; April 15, 2006

GRAND ROUNDS/TEACHING CONFERENCES

Hematologic Malignancies/ Treatment with High dose Chemotherapy and Blood and Marrow Stem Cell Transplantation; Visiting Professor Lecture, WMHS Regional Cancer Center, March 5, 2004

High Dose Chemotherapy and Stem Cell Transplantation; Oncology Grand Rounds, New York Medical College, January 29, 2004

Oncological Emergencies; Oncology Grand Rounds, New York Medical College, September 4, 2003

Megaloblastic Anemias; Hematology/Oncology Residents Lectures, New York Medical College, December 13, 2002

Microcytic Anemias;  Medical Student Lectures, New York Medical College, December 6, 2002

Acute Leukemias; Hematology/Oncology Residents Lectures, Our Lady of Mercy Medical Center, May 24, 2002

Megaloblastic Anemias; Hematology/Oncology Residents Lectures, Our Lady of Mercy Medical Center, February 1, 2002

Autologous Stem Cell Transplantation in Hematologic Malignancies; Oncology Grand Rounds, Our Lady of Mercy Medical Center, September 20, 2001

The Anemias; Hematology/Oncology Residents Lecture, Our Lady of Mercy Medical Center, September 7, 2001

High Dose Chemotherapy and Stem Cell Transplantation; Internal Medicine Ground Rounds, D’urso Hospital, June 11, 2001

Acute Myelogenous Leukemia; Oncology Grand Rounds, Our Lady of Mercy Medical Center, March 15, 2001

Diagnosis and Treatment of Acute Myelogenous Leukemia; Oncology Grand Rounds, Our Lady of Mercy Medical Center, February 22, 2001

Autologous Stem Cell Transplantation; Internal Medicine Grand Rounds, Our Lady of Mercy Medical Center, January 31, 2001

Bone Marrow Transplantation; Hematology/Oncology Residents Lectures, Our Lady of Mercy Medical Center,  December 22, 2000

Bone Marrow Transplantation; Oncology Grand Rounds, Our Lady of Mercy Medical Center, December 14, 2000

Non-Hodgkin Lymphoma; Oncology Grand Rounds, Our Lady of Mercy Medical Center, November 2, 2000

Diagnosis and Management of Anemia Patients; Medical Students Lectures, Our Lady of Mercy Medical Center, October 30, 2000

Case Management; Hematology/Oncology Residents Lectures, Our Lady of Mercy Medical Center, October 27, 2000

Non-Hodgkin Lymphoma; Oncology Grand Rounds, Our Lady of Mercy Medical Center, October, 12 2000

The Anemias; Hematology/Oncology Residents Lectures, Our Lady of Mercy Medical Center, September 22, 2000

Coagulation; Hematology/Oncology Residents Lectures, Our Lady of Mercy Medical Center, January 28, 2000

The Anemias; Hematology/ Oncology Resident Lectures, Our Lady of Mercy Medical Center, December 10, 1999

Lymphomas; Oncology/Hematology Residents Lectures, Our Lady of Mercy Medical Center, November 26, 1999

TEACHING:

September 1999 – present; Our Lady of Mercy Medical Center:

  • Medical residents, students and hematology/oncology fellows: Attending Ward Rounds, 12 hrs/wk for two months per year
  • Medical residents, and fellows; Hematology and Oncology consultations, 10 hrs/wk for 4 months per year
  • Medical students and residents: Teaching rounds and supervision, 6 hour/ week
  • Medical residents, fellows and physicians: Tumor Board Conferences, 1 hour/week
  • Medical residents, fellows and physicians: Blood and bone marrow film preparation and examination/interpretation, 2 hours/week

January 1996 – September 1999 (Evangelistria Medical Center and Public Hospitals, Cyprus)

  • Cancer prevention, 1 hour/ month
  • Cancer; Early diagnosis, 1 hour/month
  • Introduction to cancer treatment, 1 hour/month
  • Bone marrow transplantation, 1 hour/month
  • Blood and bone marrow films preparation and examination, 5 hours/week
  • Anemias, 1 hour/semester
  • Coagulopathies, 1 hour/semester
  • Thrombostasis abnormalities, 1 hour/semester

WORKSHOPS:

Accidents, Complications and side effects involving cytotoxic agents; A Workshop
for Nurses, 1991 – 1998, 2006, Cyprus, once per annum

CONTINUING MEDICAL EDUCATION:

July  5-8, 2007; European Society of Medical Oncology Conference Lugano. Lugano, Switzerland. Category 1 credit: 18 hrs

June 7-10, 2007; !2th Congress of the European Hematology Association. Vienna, Austria. CME credit: 20.25 hrs

February 23-25, 2007; 3rd European Congress on Hematologic Malignancies from Clinical Science to Clinical Practice. Athens, Greece. European external CME credit: 12 hrs
September 29-October 3, 2006; European Society for Medical Oncology 31st Congress, Istanbul, Turkey. Category 1 credit: 24 hrs 

September 22-23, 2006; Follicular Lymphomas, Chronic Lymphocytic Leukemia and Marginal Zone Lymphomas. Hellenic Hematology Society, Athens Greece
June 28-July 1, 2006; 8th World Congress on Gastrointestinal Cancer, Barcelona, Spain. Category 1 credit: 23.00 hrs

June 15-18, 2006; European Hematology Association 11th Congress, Amsterdam, Netherlands. Category 1 credit: 17.75 hrs

February 23, 2006; “Multiple Myeloma and Paraproteinemias”; Departments of “Renal Diseases” and “Haematology”, Nicosia General Hospital, Cyprus. Credit: 5 hrs

February 10-12, 2006; 8th Marianna Lordos Seminar, Larnaka, Cyprus

December 10-13, 2005; 47th ASH Annual Meeting, Atlanta, Georgia. Category 1 credit: 33.75 hrs

October 30-November 3, 2005; 13th Bi-annual Meeting of  Federation of European Cancer Societies, Paris, France. Category 1 credit: 21 hrs

June 24-25, 2005; ASCO Highlights/NOCR. Category 1 credit: 6 hrs

January 28, 2005; Combined Results of Two AI Switching Trials. University of Alabama School of Medicine. Category 1 credit: 0.25 hr

November 24, 2004; Coumadin Venous Thromboembolism Patient Safety. Hamot Medical Center. Category 1 credit: 1 hr

July 2, 2003-June 30, 2004;Current Concepts in Cancer; New York Medical College. Category 1 credit: 20 hrs

July 10, 2003-June 24, 2004; Leukemia and Lymphoma Cases; New York Medical College. Category 1 credit: 26 hrs

July 10, 2003-June 24, 2004; Oncology Grand Rounds; New York Medical Oncology. Category 1 credit: 9 hrs

July 26, 2003-June 23, 2004; Advances in Medicine Grand Rounds; New York Medival College. Category 1 credit:15 hrs

October 14,2003-May 11, 2004; Oncology Basic Science Lectures; New York Medical College. Category credit: 4 hrs

June 4-8, 2004; 40th ASCO Annual Meeting, New Orleans. Category I credit: 25.25 hrs

May 14, 2004; Proteasome Inhibition/A novel Approach to the Treatment of Multiple Myeloma; Postgraduate Institute for Medicine. Category 1 credit: 2 hrs

February 13-17, 2004; Tandem BMT Meetings; Medical College of Wisconsin. Estimated Category 1 credit: 39.75 hrs

December 23, 2003; Management of Thromboembolism in Cancer Patients; Medical Education Resources, Inc.. Category 1 credit: 1 hr

December 4, 2003; Lectures on Toxicities and Chemotherapy: A Physician’s Perspective; Medical Education Group LLC. Category 1 credit: 1 hr

July 17, 2002-June 11, 2003; Advances in Medicine; New York Medical College. Category 1 credit: 14 hrs

May 31-June 3, 2003; 39th ASCO Annual Meeting, Chicago. Category 1 credit: 27 hrs

May 30th 2003; ASCO 2003 Educational Symposia: Principles of  Molecular Biology, Chicago. Catecory 1 credit; 4 hrs

January 8, 2003-June 25, 2003; Current Concepts in Cancer; New York Medical College. Category 1 credit: 22 hrs

October 12-16, 2002;  Medical Oncology Board Review;  The George Washington University.  Category 1 credit: 38 hrs

September 10, 2002-May13, 2003; Basic Science Lectures; New York Medical College. Category 1 credit: 2 hrs

July 18, 2002-May 22, 2003: Oncology Grand Rounds; New York Medical College. Category 1credit: 11 hrs

July 11, 2002-June 26, 2003; Leukemia and Lymphoma Cases; New York Medical College. Category 1 credit: 28 hrs

March 12, 2002; First Line Therapy for Colorectal Cancer: Where Are We Now?  University of South Dakota School of Medicine. Category 1 credit: 1 hr

February 22-26, 2002;  2002 Tandem BMT Meetings; Medical College of Wisconsin.  Category 1 credit: 39.75 hrs

February 19, 2002; Osteoarthritis/ Myofacial Pain, St. Francis Hospital, NY. Category 1 credit: 1 hr

February 12, 2002; Recent Developments and Future Directions in the Treatment of Renal Cell Carcinoma (telesession), Center for Biomedical Continuing Education. Category 1 credit: 1 hr

February 11, 2002; Recent Developments and Future Directions in the Treatment of Myelodysplastic Syndromes, (telesession), Center for Biomedical Continuing Education. Category 1 Credit: 1 hr

January 24, 2002; Congestive Heart Failure, St. Francis Hospital, NY. Category 1 credit: 1 hr

January 9-December 18, 2002;Current Concepts in Cancer, New York Medical College. Catecory 1 credit: 25 hrs

January 3, 2002; Combination Therapy for Breast Cancer, The Academy of Medicine of New Jersey.  Category 1 credit: 1.5 hr

December 8-11, 2001; 43rd Annual Meeting of the American Society of Hematology, Orlando, Florida. Category 1 credit: 28 hrs

December 7, 2001; Treatment and Management of Acute Myeloid Leukemia, The University of Washington School of Medicine. Category 1 credit: 3 hrs

December 5, 2001; Platinums: New Data in the Treatment of Breast Cancer, The Academy of Medicine of New Jersey, Category 1 credit: 1 hr

November 28, 2001; Geriatric Gastroenterology Seminar, Academy of Medicine of Queens County.  Category 1 credit: 3 hrs

November 20, 2002; Multiple Myeloma Chemotherapy, University of Wisconcin Medical School, Category 1 Credit: 1 hr

November 18, 2001; Video Medical Oncology Board Review; The George Washington University.  Category 1 credit: 38 hrs

November 13, 2001- June, 11, 2002;Basic Science Lectures.New York Medical College. Category 1 credit: 3 hrs

October 13, 2001; Medical Oncology Board Review; George Washington University. Category 1 credit: 37 hrs

September 21, 2001; Ninth Annual Progress in Hematologic Malignancies and Bone Marrow Transplantation, John Hopkins, Baltimore. Category 1 credit: 7 hrs

September 6, 2001-June 27, 2002; Leukemia and Lymphoma Cases; New York Medical College. Category 1 credit: 30 hrs

August 28, 2001; Pathophysiology and Management of Chemotherapy-induced Diarrhea in the Oncology Practice, Medical Education Resources. Category 1 credit: 1 hr

July 19, 2001 – June 27, 2002; Oncology Grand Rounds, New York Medical College. Category 1 Credit: 11 hrs

July 18, 2001- June 17, 2002; Advances in Medicine, New York Medical College. Category 1 credit: 18 hrs

May 30, 2001; Geriatric Medicine for Primary Care, New York Medical College. Category 1credit: 3 hrs

March 1 – June 28, 2001; Oncology Grand Rounds, New York Medical College. Category 1 credit: 10 hrs

2001 Teleconference; Trends in Polyanalgesia, American Academy of Family Physicians. Category 1 credit: 1 hr      

May 10 – 15, 2001; 37th Annual Meeting of the American Society of Clinical Oncology, San Francisco. Category 1 credit: 25.63 hrs

April 19, 2001; Focus on tumor lysis syndrome.  Category 1 credit: 1 hr

January 11,2001; National Initiative in Continuing Medical Education, Cancer Initiative. Category 1 credit: 1 hr

January 10, 2001 – December 5, 2001; New York Medical College, Current Concepts in Cancer. Category 1 credit: 28 hrs

January 3, 2001- June 13, 2001; Advances in Medicine, New York Medical College. Category 1 credit: 12 hrs

January 5, 2000 – December 27, 2000; New York Medical College, Current Concepts in Cancer.  Category 1 credit: 25 hrs

November 14, 2000; Setting a new standard in the management of Advanced Breast Cancer. Category 1 credit: 1 hr

October 24, 2000; Dendritic cells: pacemakers of the immune system.  Category 1 credit: 1 hr

September 15, 2000; Hematologic Malignancies & BMT, Johns Hopkins, Baltimore. Category 1 credit: 6.5 hrs

September 14, 2000; Gene therapy involving immune modulation.  Category 1 credit: 1 hr

May 20 – 23, 2000; 36th Annual Meeting of the American Society of Clinical Oncology, New Orleans. Category 1 credit: 30.5 hrs

May 19, 2000; Medical informatics and Oncology practice educational symposium, ASCO-2000 Meeting, New Orleans.  Category 1 credit: 4 hrs

March 31, 2000; New Millennium Strategies and Developments in Multimodality Cancer Therapy, New York Medical College. Category 1 credit: 7 hrs

January 6, 99- December 15, 1999; Advances in Medicine, New York Medical College. Category 1 credit: 1 hr

June 2-5, 1999; VII International Conference on Malignant Lymphoma, Lugano, Switzerland. Estimated number of credits: 20 hrs

May 15-18, 1999; 35th Annual Meeting of the American Society of Clinical Oncology, Atlanta, Georgia. Category 1 credit: 31.5 hrs

May 14, 1999: The Cancer Genetics Satellite Symposium, American Society of Clinical Oncology, Atlanta, Georgia. Category 1 credit: 5.5 hrs

January 6, 1999-December 29, 1999; Current Concepts in Cancer, New York Medical College. Category 1 credit: 10 hrs           

November 6 –10, 1998; 23rd ESMO Congress, Athens, Greece. ESMO-MORA Category 1 credit: 25 hrs 

July 4 - 8 1998; 27th Congress of the International Society of Hematology and the 3rd Congress of the European Hematology Association, Amsterdam, the Netherlands.  Estimated CME credit: 20hrs

May 15-19, 1998; 34th Annual Meeting of the American Society of Clinical Oncology and Satellite Symposia, Los Angeles, USA. Category 1 credit: 21 hrs

March 15, 1998; Case studies in the Management of Chemotherapy-lnduced Thrombocytopenia, San Antonio, Texas, USA. Category 1 credit: 1.5 hrs  

March 14-17, 1998, International Symposium of Supportive Care in Cancer, San Antonio, Texas. Category 1 credit: 23 hrs     

1997 European School of Gynecological Cancer: Postgraduate and Training Course, Nicosia,   Cyprus.  Estimated Credit: 20hrs

November 3-5, 1996; 21st European Society of Medical Oncology Congress, Vienna, Austria.  ESMO MORA Category 1 credit: 25 hrs

September 27-28, 1996- Annual Meeting of the European Group of Breast Cancer, Cyprus, CME credit: 11 hr